Company description

Clinilabs is a specialised CRO focused on the development of drugs, devices and technologies targeting central nervous system (CNS) disorders. Headquartered in the United States, the company supports pharmaceutical, biotechnology and medical device organisations globally, offering end-to-end clinical development services.

Founded around 2000, Clinilabs has over 25 years of experience in CNS research and has completed more than 800 clinical trials across over 25 neurological and psychiatric indications. The company has contributed to the development of more than 30 marketed products, establishing itself as a specialist partner in neurotherapeutic development.

Clinilabs differentiates itself through its exclusive focus on CNS disorders, including psychiatry, neurology, substance use disorders and rare neurological conditions. Its global footprint spans North America, Europe and Asia, enabling the execution of multi-regional clinical trials with deep therapeutic expertise.

The company combines clinical operations, scientific expertise and advanced technologies to manage Phase I–III trials, with a strong emphasis on complex CNS indications that require specialised patient populations, endpoints and trial design. Clinilabs positions itself as “the CRO for CNS,” offering indication-level expertise and tailored solutions for neurotherapeutic development.

Key products and services

Clinical development services

• Phase I–III clinical trial management
• Study start-up, monitoring and execution
• Multi-regional CNS clinical trials
• Project and programme management

Early phase and specialised CNS research

• First-in-human and early-phase studies
• Clinical research units for CNS trials
• Specialised trial design for complex neurological conditions

Clinical trial services and technology

• Data management and biostatistics
• Clinical trial technology and digital tools
• Biomarker and endpoint assessment

Core laboratory services (Corelabs)

• Neuroimaging and CNS biomarker analysis
• Centralised laboratory services for clinical trials
• Data integration and analysis support

Regulatory and advisory services

• Regulatory strategy and submissions support
• Clinical development consulting
• Guidance on CNS-specific regulatory requirements

Therapeutic expertise

• Psychiatry and mental health disorders
• Neurology and neurodegenerative diseases
• Substance use disorders
• Rare and ultra-rare CNS conditions

By focusing exclusively on central nervous system disorders, Clinilabs offers deep therapeutic expertise and specialised clinical capabilities that differentiate it from generalist CROs. Its integrated services, global reach and strong track record in neurotherapeutics position the company as a strategic partner for organisations developing innovative treatments in complex CNS indications.